Insider Selling: NIOX Group (LON:NIOX) Insider Sells 3,824 Shares of Company Stock

NIOX Group Plc (LON:NIOX) insider Sarah Duncan sold 3,824 shares of the stock in a transaction on Tuesday, October 27th. The stock was sold at an average price of GBX 80, for a total value of £3,059.20.

NIOX Group Stock Performance

Shares of NIOX traded up GBX 0.20 during midday trading on Wednesday, hitting GBX 64.60. 281,066 shares of the stock traded hands, compared to its average volume of 902,221. NIOX Group Plc has a 1-year low of GBX 53.84 and a 1-year high of GBX 80. The firm has a market capitalization of £271.88 million, a PE ratio of 39.63 and a beta of 0.92. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.94 and a current ratio of 4.60. The business’s 50 day moving average price is GBX 67.34 and its two-hundred day moving average price is GBX 63.13.

NIOX Group (LON:NIOX) last released its quarterly earnings results on Wednesday, September 30th. The company reported GBX 1.41 EPS for the quarter. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%. Equities research analysts predict that NIOX Group Plc will post 1.17 EPS for the current fiscal year.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.